Terms: = Testicular cancer AND EGFR, mENA, 1956, ENSG00000146648, P00533, ERBB1, ERBB AND Treatment
19 results:
1. Longitudinal kidney function outcome in aging testicular cancer survivors.
Nome RV; Cvancarova Småstuen M; Bjøro T; Kiserud CE; Fosså SD
Acta Oncol; 2020 Apr; 59(4):467-474. PubMed ID: 32043400
[No Abstract] [Full Text] [Related]
2. EGF Receptor and mTORC1 Are Novel Therapeutic Targets in Nonseminomatous Germ Cell Tumors.
Chen KS; Fustino NJ; Shukla AA; Stroup EK; Budhipramono A; Ateek C; Stuart SH; Yamaguchi K; Kapur P; Frazier AL; Lum L; Looijenga LHJ; Laetsch TW; Rakheja D; Amatruda JF
Mol Cancer Ther; 2018 May; 17(5):1079-1089. PubMed ID: 29483210
[TBL] [Abstract] [Full Text] [Related]
3. Epidermal growth factor receptor and epididymis invasion as prognostic biomarkers in clinical stage I testicular germ cell tumours.
Sanmamed MF; Esteban E; Uriol E; Zarate R; Capelan M; Muriel C; Crespo G; Berros JP; Pardo-Coto P; Perez Q; Alvarez-Fernández C; Jiménez Fonseca P; Luque M; Astudillo A
J Transl Med; 2017 Mar; 15(1):62. PubMed ID: 28320414
[TBL] [Abstract] [Full Text] [Related]
4. Effects of bleomycin and antioxidants on the fatty acid profile of testicular cancer cell membranes.
Cort A; Ozben T; Melchiorre M; Chatgilialoglu C; Ferreri C; Sansone A
Biochim Biophys Acta; 2016 Feb; 1858(2):434-41. PubMed ID: 26656160
[TBL] [Abstract] [Full Text] [Related]
5. Next generation sequencing analysis of platinum refractory advanced germ cell tumor sensitive to Sunitinib (Sutent®) a Vegfr2/PDGFRβ/c-kit/ FLT3/RET/CSF1R inhibitor in a phase II trial.
Subbiah V; Meric-Bernstam F; Mills GB; Shaw KR; Bailey AM; Rao P; Ward JF; Pagliaro LC
J Hematol Oncol; 2014 Aug; 7():52. PubMed ID: 25085632
[TBL] [Abstract] [Full Text] [Related]
6. Reliability of estimated glomerular filtration rate in patients treated with platinum containing therapy.
Lauritsen J; Gundgaard MG; Mortensen MS; Oturai PS; Feldt-Rasmussen B; Daugaard G
Int J Cancer; 2014 Oct; 135(7):1733-9. PubMed ID: 24585507
[TBL] [Abstract] [Full Text] [Related]
7. Effectivity of pazopanib treatment in orthotopic models of human testicular germ cell tumors.
Juliachs M; Vidal A; Del Muro XG; Piulats JM; Condom E; Casanovas O; Graupera M; Germà JR; Villanueva A; Viñals F
BMC Cancer; 2013 Aug; 13():382. PubMed ID: 23937707
[TBL] [Abstract] [Full Text] [Related]
8. erbbs inhibition by lapatinib blocks tumor growth in an orthotopic model of human testicular germ cell tumor.
Juliachs M; Castillo-Ávila W; Vidal A; Piulats JM; Garcia Del Muro X; Condom E; Hernández-Losa J; Teixidó C; Pandiella A; Graupera M; Casanovas O; Germà JR; Villanueva A; Viñals F
Int J Cancer; 2013 Jul; 133(1):235-46. PubMed ID: 23292912
[TBL] [Abstract] [Full Text] [Related]
9. Estrogens promote proliferation of the seminoma-like TCam-2 cell line through a GPER-dependent ERα36 induction.
Wallacides A; Chesnel A; Ajj H; Chillet M; Flament S; Dumond H
Mol Cell Endocrinol; 2012 Mar; 350(1):61-71. PubMed ID: 22138413
[TBL] [Abstract] [Full Text] [Related]
10. Tyrosine kinase expression in pulmonary metastases and paired primary tumors.
Muehling BM; Toelkes S; Schelzig H; Barth TF; Sunder-Plassmann L
Interact Cardiovasc Thorac Surg; 2010 Feb; 10(2):228-31. PubMed ID: 19948538
[TBL] [Abstract] [Full Text] [Related]
11. CD133 is indicative for a resistance phenotype but does not represent a prognostic marker for survival of non-small cell lung cancer patients.
Salnikov AV; Gladkich J; Moldenhauer G; Volm M; Mattern J; Herr I
Int J Cancer; 2010 Feb; 126(4):950-8. PubMed ID: 19676044
[TBL] [Abstract] [Full Text] [Related]
12. Epidermal growth factor receptor protein expression and gene amplification in the chemorefractory metastatic embryonal carcinoma.
Wang X; Zhang S; Maclennan GT; Biermann K; Foster RS; Beck SD; Cheng L
Mod Pathol; 2009 Jan; 22(1):7-12. PubMed ID: 18660793
[TBL] [Abstract] [Full Text] [Related]
13. The molecular biology and immunology of glioblastoma multiforme (GBM) with the presentation of an immunotherapy protocol for a clinical trial.
Sinkovics JG; Horvath JC
Acta Microbiol Immunol Hung; 2006 Dec; 53(4):367-429. PubMed ID: 17278710
[TBL] [Abstract] [Full Text] [Related]
14. [New therapeutic targets in testicular cancer: contribution of molecular biology].
Paule B
Prog Urol; 2004 Apr; 14(2):243-5. PubMed ID: 15217149
[TBL] [Abstract] [Full Text] [Related]
15. Profile of placental alkaline phosphatase expression in human malignancies: effect of tumour cell activation on alkaline phosphatase expression.
Dabare AA; Nouri AM; Cannell H; Moss T; Nigam AK; Oliver RT
Urol Int; 1999; 63(3):168-74. PubMed ID: 10738188
[TBL] [Abstract] [Full Text] [Related]
16. treatment of stage I testis seminoma by radiotherapy: long-term results--a 30-year experience.
Giacchetti S; Raoul Y; Wibault P; Droz JP; Court B; Eschwege F
Int J Radiat Oncol Biol Phys; 1993 Sep; 27(1):3-9. PubMed ID: 8365943
[TBL] [Abstract] [Full Text] [Related]
17. Second non-germ cell malignancies after radiotherapy of testicular cancer with or without chemotherapy.
Fosså SD; Langmark F; Aass N; Andersen A; Lothe R; Børresen AL
Br J Cancer; 1990 Apr; 61(4):639-43. PubMed ID: 2109999
[TBL] [Abstract] [Full Text] [Related]
18. [treatment of acute lymphoblastic leukaemia in children over twenty years (author's transl)].
Jacquillat C; Weil M; Auclerc MF; Schaison G; Bernard J
Nouv Presse Med; 1981 May; 10(23):1903-8. PubMed ID: 6941217
[TBL] [Abstract] [Full Text] [Related]
19. Malignant testis tumors. Survival in 53 patients with minimum 5 years observation time.
Gude H; Varhaug JE; Høisaeter PA
Scand J Urol Nephrol; 1979; 13(3):245-8. PubMed ID: 531526
[TBL] [Abstract] [Full Text] [Related]
